Congress passes prescription-drug bill targeting opioid abuse
This week, Congress passed the Comprehensive Addiction and Recovery Act (CARA), which aims to combat prescription drug abuse, especially opioids. Read More »
HSS nondiscrimination rule imposed on health care providers
Pharmacies required to follow nondiscrimination regulations when serving customers. Read More »
Chef Elizabeth Falkner joins push to educate the public about atopic dermatitis
Award-winning chef teams with pharmaceutical companies and dermatology organizations in the 'Understand AD' campaign. Read More »
FDA approves Prevnar 13 vaccine for adults ages 18 to 49
FDA approves expanded age range for the pneumonia vaccine. Read More »
VCS recognized by Conquer Cancer Foundation for clinical trials
Virginia Cancer Specialists (VCS) recently announced that it has been recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) because of its dedication to ensuring patients participate in high-quality clinical trials. Read More »
13 interns join Prime's summer program
13 college students join the full-time, paid internship program at Prime. Read More »
FDA approves dry eye medication Xiidra
Xiidra has been approved by the U.S. Food and Drug Administration (FDA) to treat the signs and symptoms of dry eye disease. Read More »
FDA accepts new drug applications for Teva asthma medications
Fluticasone propionate/salmeterol and fluticasone propionate new drug applications accepted by FDA. Read More »
Positive results announced in two diabetes Phase III studies
Titratable fixed-ratio combination found superior to lixisenatide and insulin glargine. Read More »
Culturelle launches new probiotic supplement
Pro-Well 3-in-1 Complete Formula added to the Culturelle probiotics line to support overall health and wellness. Read More »
FDA approves two Teligent ANDAs
Teligent Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted approvals for its abbreviated new drug applications (ANDAs) for Triamcinolone Acetonide Lotion USP, 0.1 percent and Triamcinolone Acetonide Lotion USP, 0.025 percent. Read More »
Protagonist elects William D. Waddill to Board of Directors
William D. Waddill, who is the SVP and CFO for Calithera Biosciences, has been elected to the Protagonist Therapeutics Inc. Board of Directors, Protagonist announced last week. Read More »
CVS Health Research Institute releases findings of Medication Reconciliation Program study
The CVS Health Research Institute recently released the results of a new study that has determined that medication reconciliation programs have decreased hospital readmissions. Read More »
First absorbable drug-emitting stent approved by FDA
Stent releases drug to reduce scar tissue in coronary arteries after angioplasty. Read More »
Genticel approaches Eumedix for strategic advising
Genticel has announced that it has approached Eumedix, a renowned European corporate finance specialist, for strategic advising. Read More »
CVS Health continues efforts to reduce children's secondhand smoke exposure
Provides grant to American Academy of Pediatrics to improve providers' counseling on tobacco and secondhand smoke exposure. Read More »
MinuteClinic introduces travel health services for summer 2016
CVS Pharmacy MinuteClinic locations across the country recently introduced health services and immunizations related to travel to assist patients in their preparation for the travel season. Read More »
Kalb joins Amarin as SVP and CFO
Seasoned executive joins Amarin senior management team. Read More »
First non-surgical double chin treatment receives positive opinion in Europe
BELKYRA received a positive opinion by the Swedish Medical Products Agency. Read More »
FDA grants BTD for IMBRUVICA treatment for cGVHD
FDA also grants Orphan Drug Designation for the therapy. Read More »
Alerts Sign-up